These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8777987)

  • 1. Blockade of muscarinic transmission increases the frequency of diabetes after low-dose alloxan challenge in the mouse.
    Ahrén B; Sundkvist G; Mulder H; Sundler F
    Diabetologia; 1996 Apr; 39(4):383-90. PubMed ID: 8777987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chemical sympathectomy by means of 6-hydroxydopamine on insulin secretion and islet morphology in alloxan-diabetic mice.
    Kvist-Reimer M; Sundler F; Ahrén B
    Cell Tissue Res; 2002 Feb; 307(2):203-9. PubMed ID: 11845327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific reduction of galanin content in the pancreas in alloxan diabetes in the mouse.
    Dunning BE; Ahrén B
    Acta Physiol Scand; 1993 Oct; 149(2):215-9. PubMed ID: 7505518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of alloxan in mice.
    Ahrén B; Sundkvist G
    Int J Pancreatol; 1995 Apr; 17(2):197-201. PubMed ID: 7622942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of ALR/Lt islets to free radical-mediated diabetogenic stress is inherited as a dominant trait.
    Mathews CE; Leiter EH
    Diabetes; 1999 Nov; 48(11):2189-96. PubMed ID: 10535453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal B-cell function in neonatally streptozotocin-diabetic rats: insensitivity to alloxan toxicity.
    Grill V; Westberg M
    Endocrinology; 1987 Dec; 121(6):2171-6. PubMed ID: 2445559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silymarin induces recovery of pancreatic function after alloxan damage in rats.
    Soto C; Mena R; Luna J; Cerbón M; Larrieta E; Vital P; Uría E; Sánchez M; Recoba R; Barrón H; Favari L; Lara A
    Life Sci; 2004 Sep; 75(18):2167-80. PubMed ID: 15325843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet amyloid polypeptide (amylin)-deficient mice develop a more severe form of alloxan-induced diabetes.
    Mulder H; Gebre-Medhin S; Betsholtz C; Sundler F; Ahrén B
    Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E684-91. PubMed ID: 10751203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral trypsin-inhibitor-induced improvement of the exocrine and endocrine pancreatic functions in alloxan diabetic rats.
    Ihse I; Lundquist I; Arnesjö B
    Scand J Gastroenterol; 1976; 11(4):363-8. PubMed ID: 779003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallothionein does not protect mouse endocrine cells from damage induced by alloxan injection.
    Minami T; Shimizu M; Tanaka H; Okazaki Y; Cherian MG
    Toxicology; 1999 Jan; 132(1):33-41. PubMed ID: 10199579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proglumide, a cholecystokinin receptor antagonist, exacerbates alloxan-induced diabetes mellitus in Swiss mice.
    Parmar NS; Tariq M; Ageel AM
    J Pharm Pharmacol; 1987 Dec; 39(12):1028-30. PubMed ID: 2894431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dynamics of insulin secretion in dogs with alloxan diabetes].
    Dagaeva LN; Belikova FS; Podotykina OI; Makarova AV
    Biull Eksp Biol Med; 1978 Mar; 85(3):278-81. PubMed ID: 352428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular target structures in alloxan-induced diabetes in mice.
    im Walde SS; Dohle C; Schott-Ohly P; Gleichmann H
    Life Sci; 2002 Aug; 71(14):1681-94. PubMed ID: 12137914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of islet amyloid polypeptide (amylin) and insulin in experimental diabetes in rodents.
    Mulder H; Ahrén B; Sundler F
    Mol Cell Endocrinol; 1995 Oct; 114(1-2):101-9. PubMed ID: 8674834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in the diabetogenic effect of alloxan in mice by treatment with the antineoplastic agent ICRF-187.
    El-Hage AN; Herman EH; Ferrans VJ
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):509-23. PubMed ID: 7036302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal D cell secretion in alloxan-diabetes: influence by drug and aberrant metabolism.
    Grill V; Efendić S
    Am J Physiol; 1984 Jun; 246(6 Pt 1):E483-92. PubMed ID: 6204535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of extracts of Murraya koenigii leaves on the levels of blood glucose and plasma insulin in alloxan-induced diabetic rats.
    Vinuthan MK; Girish Kumar V; Ravindra JP; Jayaprakash ; Narayana K
    Indian J Physiol Pharmacol; 2004 Jul; 48(3):348-52. PubMed ID: 15648408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan.
    Rooman I; Bouwens L
    Diabetologia; 2004 Feb; 47(2):259-65. PubMed ID: 14666367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective effect of indomethacin on alloxan-induced diabetes in rat].
    Xu WX; Yu JR
    Sheng Li Xue Bao; 1992 Apr; 44(2):202-8. PubMed ID: 1621111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein reduces hyperglycemia and islet cell loss in a high-dosage manner in rats with alloxan-induced pancreatic damage.
    Yang W; Wang S; Li L; Liang Z; Wang L
    Pancreas; 2011 Apr; 40(3):396-402. PubMed ID: 21206328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.